Kerrebijn, K.F.

study treatment group asthma patient children airway salmeterol beclomethasone inhaled fev 1 function period symptom asthmatic effect growth inhaled corticosteroids inhaled corticosteroid respir asthmatic children difference change bdp 400 salm salbutamol corticosteroids airway responsiveness hospital corticosteroid postbronchodilator childhood measurement methacholine bazpl bazic improvement baseline kerrebijn treatment period pd 20 methacholine responsiveness lung function treatment groups pd 20 bdp 400 group bdp 400 groups childhood asthma airway function figure bronchodilation value result bdp 800 group inhalation subject number expiratory comparison evening lung function measurements morning center medication run-in period visit verberne essen-zandvliet height month analysis van essen-zandvliet salmeterol group salmeterol 50 g study medication volume run-in beclomethasone 200 g development follow-up table